A detailed history of R Squared LTD transactions in Rani Therapeutics Holdings, Inc. stock. As of the latest transaction made, R Squared LTD holds 2,170 shares of RANI stock, worth $2,994. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,170
Holding current value
$2,994
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 22, 2025

BUY
$1.3 - $3.18 $2,821 - $6,900
2,170 New
2,170 $2.97 Million

Others Institutions Holding RANI

About Rani Therapeutics Holdings, Inc.


  • Ticker RANI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,492,000
  • Market Cap $33.8M
  • Description
  • Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...
More about RANI
Track This Portfolio

Track R Squared LTD Portfolio

Follow R Squared LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of R Squared LTD, based on Form 13F filings with the SEC.

News

Stay updated on R Squared LTD with notifications on news.